Leishmaniasis recidivans
ICD-10 B55.1 is a billable code used to indicate a diagnosis of leishmaniasis recidivans.
Leishmaniasis recidivans is a chronic form of leishmaniasis caused by the protozoan parasites of the genus Leishmania, primarily transmitted through the bite of infected sandflies. This condition is characterized by recurrent skin lesions that may appear after a period of apparent healing. The lesions can be ulcerative and are often accompanied by systemic symptoms such as fever, malaise, and lymphadenopathy. The recidivans form is particularly noted for its tendency to recur in the same location, often in individuals who have previously been treated for leishmaniasis. Diagnosis is typically made through clinical evaluation, serological tests, and sometimes biopsy of the lesions. Treatment usually involves the use of antimonial compounds, amphotericin B, or miltefosine, depending on the severity and extent of the disease. The management of leishmaniasis recidivans requires careful monitoring and may necessitate multiple treatment courses to achieve resolution of symptoms and prevent further recurrences.
Detailed history of previous infections, treatment responses, and current symptoms.
Patients presenting with recurrent skin lesions after treatment for leishmaniasis.
Consideration of co-morbid conditions that may complicate treatment.
Photographic evidence of lesions, detailed descriptions of lesion characteristics.
Patients with chronic skin lesions that may be misdiagnosed as other dermatological conditions.
Differentiation from other skin conditions such as cutaneous sarcoidosis or granuloma annulare.
Used when a biopsy is performed to confirm leishmaniasis.
Pathology report and clinical notes supporting the need for biopsy.
Infectious disease specialists should ensure that the biopsy is clearly linked to the diagnosis.
Leishmaniasis recidivans is primarily caused by the protozoan parasite Leishmania braziliensis, transmitted through the bite of infected sandflies.
